CerS2 ko in vivo reduces pro-inflammatory ceramides and improves doxorubicin mediated cardiotoxicity
28 August 2023 (09:15 - 10:00)
Organised by: 
About the speaker
University hospital Jena, Jena (Germany)
6 More presentations in this session
Doctor I. Cheang (Nanjing, CN)
Prognostic value of 6-minute walking test for early prediction of doxorubicin induced cardiotoxicity
Mrs G. Muckiene (Kaunas, LT)
Doctor G. Oristrell Santamaria (Barcelona, ES)
Associate Professor K. Urbanek (Naples, IT)
Access the full session
The Event
ESC Congress 2023
28 August 2023
09:15 CET
You may be interested in
Congress Presentation
Congress Presentation
Congress Session
